Fri, Jul 16, 2021

CIRCB contribution to a COVID-19 Molecular Diagnostics in Cameroon

This project was coordinated by the ICGEB and implemented in partnership with reference testing laboratories in Africa. ICGEB Member States, Cameroon, Ethiopia, Kenya, and Nigeria, have taken part in a pilot study to assess the efficacy of a novel diagnostic tool in diverse settings. Dr Joseph Fokam (TMA2015CDF1027) was the local PI in Cameroon.

This pilot study, performed during the period September 2020-May 2021, contributed to the accuracy in detecting SARS-CoV-2 in resource-limited settings. It evaluated the diagnostic performance of RT-LAMP in terms of intrinsic (sensitivity, specificity) and extrinsic (positive and negative predictive values) characteristics according to SARS-CoV-2 viral load estimates provided by the conventional RT-qPCR in four LMICs of Sub-Saharan Africa. Results from the study show that RT-LAMP represents a formidable alternative to RT-qPCR. New England BioLabs freely contributed its LAMP technology to the study, and the Bill & Melinda Gates Foundation funded the project (INV – 022816).

To learn more about this exciting project visit https://www.youtube.com/watch?v=F-xSlulkN-4

Articles

Featured Mon, Jul 14, 2025

Test Article With Image

Test article 14 July 2025 with image TL

Tue, May 30, 2023

Virtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023

The Stop TB Partnership Working Group on New TB Vaccines (WGNV) and the National Institute for Allergy and Infectious Diseases (NIAID)are co-hosting a workshop on the topic of Recognition and Control of Mtb Infected Cells: From Basics to the Clinic. This workshop is intended to address the need for correlates and to identify platforms that measure recognition or control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for Research and Development of New TB Vaccines and the Strategic Framework for New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.

The overall goals of this workshop are to:

elucidate the mechanisms by which the immune system recognizes the Mtb-infected cell
explore the degree to which such recognition can lead to control of the intracellular microbe, and
discuss the translational implications of these observations

The workshop format will be largely discussion-based. Each session will have three short presentations that will provide a high-level overview of key topics within the session theme, followed by a discussion between the session chairs, speakers, and participants.

Click here to view the programme and speakers.

This workshop is free of charge and open to any participants interested in this topic.

Tue, May 30, 2023

Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023

The International Society for Infectious Diseases (ISID) and the Swiss Society for Infectious Diseases (SSI) are inviting applications for their joint Infectious Diseases Research Fellowship Program. The purpose of this programme is to support infectious disease physicians and scientists from under-resourced countries through multidisciplinary clinical and laboratory training at a select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID Fellowship programme is open to applicants who are 40 years or younger, citizens and permanent residents of under-resourced countries or Eastern Europe. The deadline for applications is 16 June 2023.

More information: https://na.eventscloud.com/eSites/748378/Homepage